AVBP β€” ArriVent Biopharma Inc

Ownership history in Corient IA LLC  Β·  1 quarter on record

This page tracks every 13F SEC filing in which Corient IA LLC reported a position in ArriVent Biopharma Inc (AVBP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.46% (2025 Q3)
πŸ“Š Avg. % of fund
0.46%
πŸ“… First filed
2025 Q3
πŸ“… Last filed
2025 Q3
⏱ Quarters held
1
% of Fund (quarterly)    AVBP price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 1 quarter  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 33,500 β€” β€” 0.46% $618K $18.45

🏒 Other funds also holding AVBP

As of 2025 Q4 β€” sorted by position size

General Catalyst Group Management, LLC 3Y 7Y 13.56% AIHC Capital Management Ltd 12.16% Octagon Capital Advisors LP 3Y 4.81% Novo Holdings A/S 3Y 7Y 3.03% HHLR ADVISORS, LTD. 3Y 7Y 2.55% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.69% Rosalind Advisors, Inc. 1.53% Sofinnova Investments, Inc. 3Y 7Y 1.47% Fund 1 Investments, LLC 3Y 1.39% ORBIMED ADVISORS LLC 3Y 7Y 1.24%
← Back to Corient IA LLC Holdings